Literature DB >> 12459932

On the protection against methamphetamine-induced neurotoxicity by benzamide, a PARP inhibitor.

Esther O'Shea1, Veronica Sanchez, Jorge Camarero, A Richard Green, M Isabel Colado.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12459932     DOI： 10.1007/s00213-002-1323-8

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN： 0033-3158            Impact factor:   4.530


× No keyword cloud information.
  14 in total

1.  Studies on the neuroprotective effect of pentobarbitone on MDMA-induced neurodegeneration.

Authors:  M I Colado; B Esteban; E O'Shea; R Granados; A R Green
Journal:  Psychopharmacology (Berl)       Date:  1999-03       Impact factor: 4.530

2.  Peroxynitrite plays a role in methamphetamine-induced dopaminergic neurotoxicity: evidence from mice lacking neuronal nitric oxide synthase gene or overexpressing copper-zinc superoxide dismutase.

Authors:  S Z Imam; G D Newport; Y Itzhak; J L Cadet; F Islam; W Slikker; S F Ali
Journal:  J Neurochem       Date:  2001-02       Impact factor: 5.372

3.  Methamphetamine administration causes overexpression of nNOS in the mouse striatum.

Authors:  X Deng; J L Cadet
Journal:  Brain Res       Date:  1999-12-18       Impact factor: 3.252

4.  Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat.

Authors:  J E Malberg; K E Sabol; L S Seiden
Journal:  J Pharmacol Exp Ther       Date:  1996-07       Impact factor: 4.030

5.  nNOS inhibitors attenuate methamphetamine-induced dopaminergic neurotoxicity but not hyperthermia in mice.

Authors:  Y Itzhak; J L Martin; S F Ail
Journal:  Neuroreport       Date:  2000-09-11       Impact factor: 1.837

6.  Role for excitatory amino acids in methamphetamine-induced nigrostriatal dopaminergic toxicity.

Authors:  P K Sonsalla; W J Nicklas; R E Heikkila
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

7.  Benzamide, an inhibitor of poly(ADP-ribose) polymerase, attenuates methamphetamine-induced dopamine neurotoxicity in the C57B1/6N mouse.

Authors:  C Cosi; P Chopin; M Marien
Journal:  Brain Res       Date:  1996-10-07       Impact factor: 3.252

8.  Role of hyperthermia in the protective action of clomethiazole against MDMA ('ecstasy')-induced neurodegeneration, comparison with the novel NMDA channel blocker AR-R15896AR.

Authors:  M I Colado; R Granados; E O'Shea; B Esteban; A R Green
Journal:  Br J Pharmacol       Date:  1998-06       Impact factor: 8.739

9.  Methamphetamine-induced hyperthermia and dopaminergic neurotoxicity in mice: pharmacological profile of protective and nonprotective agents.

Authors:  D S Albers; P K Sonsalla
Journal:  J Pharmacol Exp Ther       Date:  1995-12       Impact factor: 4.030

10.  Further studies of the role of hyperthermia in methamphetamine neurotoxicity.

Authors:  J F Bowyer; D L Davies; L Schmued; H W Broening; G D Newport; W Slikker; R R Holson
Journal:  J Pharmacol Exp Ther       Date:  1994-03       Impact factor: 4.030
View more
  1 in total

1.  A qualitative analysis of GHB use among gay men: Reasons for use despite potential adverse outcomes.

Authors:  Joseph J Palamar; Perry N Halkitis
Journal:  Int J Drug Policy       Date:  2006-01-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.